Serendipity strikes cancer cells
19 May, 2003 by Jeremy TorrResearchers at the University of NSW looking for a protein analysis tool have accidentally come up with a drug that can halt cell growth in tumours.
Antisense wins $1.1m Start grant for psoriasis project
19 May, 2003 by Melissa TrudingerMelbourne company Antisense Therapeutics has won a $AUD1.1 million R&D Start grant, in the first round of funding awarded since the Federal government reopened the program late last year.
Euro giant Serono to develop Amrad compound
09 May, 2003 by Melissa TrudingerMelbourne-based Amrad has granted an exclusive license to Swiss/US company Serono to develop and commercialise emfilermin for use in reproductive health indications, under an option in the original partnership between the two companies.
WEHI researchers using stem cells to prevent diabetes
09 May, 2003 by Melissa TrudingerResearchers at the Walter and Eliza Hall Institute are devising a stem-cell-based approach designed to prevent the development of type 1 diabetes in susceptible individuals by engineering the haematopoietic stem cells to express proinsulin after differentiation into antigen presenting cells.
Malaria vaccine delivers unexpected bonus to Prima
07 May, 2003 by Melissa TrudingerPrima BioMed subsidiary PanVax and researchers at the Austin Research Institute have demonstrated that a malaria vaccine developed using its DCtag adjuvant technology is able to eradicate established disease in mice infected with malaria.
HIV study returns good results for Biota technology
30 April, 2003 by Pete YoungImpressive US test results which indicate the effectiveness of a potential anti-HIV/AIDS drug is generating good news on three levels for anti-viral specialist Biota Holdings.
AustCancer ditches its mining past
24 April, 2003 by Jeremy TorrAnother West Australian ex-mining listing has finally shaken off the last vestiges of mineral exploration and turned completely to the world of biotech.
GTG appointments expected to boost test service
22 April, 2003 by Melissa TrudingerMelbourne biotechnology company Genetic Technologies (ASX: GTG) has appointed two Australian scientists to assist it with the set up of its new cancer susceptibility genetic testing service.
BresaGen soars on Parkinson's results
14 April, 2003 by Melissa TrudingerAustralian stem cell company BresaGen has demonstrated functional recovery from the effects of Parkinson's disease in a rat model treated with human dopaminergic neurons derived from human embryonic stem cells.
Singapore: report slams non-ethical research practices, director fired
09 April, 2003 by Kate WebsterSingapore's efforts to become a global hub for the biomedical sciences faced its first major hurdle last week with the sacking of world-renowned British neurologist, Dr Simon Shorvon, from his post as the director of the National Neuroscience Institute.
Study backs theory that TB jab could guard against asthma
07 April, 2003 by Graeme O'NeillA Sydney epidemiological study has given further weight to a theory that exposure to non-viral respiratory infections in childhood may protect against asthma later in life.
The research road to doctorate
27 March, 2003 by Graeme O'NeillWorking hard for low pay, but Graeme O'Neill reports that the pursuit of a PhD could be the most rewarding time in a scientist's life.
US firm claims Vision Bio infringed patents
26 March, 2003 by Melissa TrudingerA legal battle has erupted over Vision BioSystems' new cancer detection instruments, with US company Ventana Medical Systems filing claims alleging patent infringement in a US court last week.
Prana teams with NSV, Schering
24 March, 2003 by Melissa TrudingerMelbourne company Prana Biotechnology has announced an agreement with Neurosciences Victoria and German pharma Schering worth up to $AUD7.5 million over the next three to five years.
CSIRO fields cancer diagnosis tools
20 March, 2003 by Jeremy TorrCSIRO Bioinformatics, a spin-off company from CSIRO Mathematical and Information Sciences, has developed new statistical methods it says could lead to improved diagnosis and treatment of cancers.
